Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
about
Promising biological therapies for ulcerative colitis: A review of the literatureClinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent updateResponse to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.Immunomodulatory and anti-inflammatory effects of chondroitin sulphate.Overview of biologic therapy for Crohn's disease.Maintenance treatment with infliximab for the management of Crohn's disease in adults.Adalimumab in ulcerative colitis: hypes and hopes.State-of-the-art medical prevention of postoperative recurrence of Crohn's disease.Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.Tumor necrosis factor suppresses NR5A2 activity and intestinal glucocorticoid synthesis to sustain chronic colitis.Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.Malignant melanoma of the ileo-anal pouch anastomosis after restorative proctocolectomy for ulcerative colitis: report of a caseEarly diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.Therapeutic Targets for Emerging Biologic Therapies in IBD.Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease.Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study.Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway*
P2860
Q26776139-AA4E944A-630E-461E-B663-6FE4900823EAQ26994776-F47126AC-C8FC-4E5D-BE0E-5935383FAA78Q34167771-30906C98-6028-4507-BF20-19E7A16974B7Q37310621-82C615C2-BE79-4BBC-834B-72AA9CDD8DB1Q37547257-8F4DA181-D375-4EE2-AE9A-71A5A8FD675CQ37586911-5A6593D8-F74D-4A61-93D0-F89A1A541D0BQ37816445-29A78771-7275-4056-8B98-2A1010346AEAQ38104578-3F64CFFA-1E1C-4F60-BCF8-90E8BE21D200Q38191334-47C7E531-A103-4821-9C69-CB9F21EA5F8AQ38881849-9D610D4D-6314-4A73-90C3-9A69518A85FFQ39020790-ACF09F6A-578C-48B5-A7B9-4A5988A0DF78Q39426072-51B3A522-6DF8-45BF-80F0-FB95ED8C10A0Q42029056-FE66E2E7-375B-4863-9DBD-8288D5045EFEQ42632507-66A6C0CF-5899-48ED-851F-956FFC337A7EQ45839795-CDF48B9A-4C35-47C6-9D1E-DAF4ACBCB47FQ46495260-BDB8C86C-14DE-4B69-9882-D1D02A97C849Q47368079-B1B95862-1AD6-48DE-A49F-D18BFBA36875Q51584924-FD321349-31DC-4C65-8563-6E0BA020C3B5Q54318216-E3C64C71-F95E-478B-B3E1-242C8A2B011FQ57265340-BB0A8DA8-EEBF-42CC-BDD1-CF679E9A88FD
P2860
Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@en
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@nl
type
label
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@en
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@nl
prefLabel
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@en
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@nl
P1476
Mechanisms of action of inflix ...... anti-inflammatory multitasker.
@en
P2093
P304
P356
10.1016/S1590-8658(08)60530-7
P478
40 Suppl 2
P577
2008-07-01T00:00:00Z